Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.75 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | HPGD | P15428 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.68 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.68 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.68 |
| ▸ | GGT1 | P19440 | 1/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylaspirinate SCHEMBL29389369 | 1.00 | HSD17B10 (0.75) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL21449134 | 0.88 | PTGS2 (0.68) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| Diplosalsalate SCHEMBL25398 | 0.86 | KDM4E (1.00) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL2473332 | 0.86 | KDM4E (1.00) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| Diplosalsalate SCHEMBL30590970 | 0.86 | KDM4E (1.00) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL1282647 | 0.85 | HSD17B10 (0.64) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL5710896 | 0.85 | HSD17B10 (0.64) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL21526685 | 0.85 | HSD17B10 (0.56) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL2887992 | 0.84 | PTGS2 (0.63) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL15267403 | 0.84 | PTGS2 (0.63) | HSD17B10KDM4ELMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1904 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| US-20210145763-A1 | LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE | EYE CO PTY LTD. (AU) | 2021-05-20 | — | — | US | claimed |
| EP-3773651-A1 | LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE | Eye Co Pty Ltd. (AU) | 2021-02-17 | — | — | EP | claimed |
| WO-2019191800-A1 | LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE | EYE CO PTY LTD (AU) | 2019-10-10 | — | — | WO | claimed |
| EP-2822532-B1 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE | COVESTRO DEUTSCHLAND AG (DE) | 2018-09-19 | — | — | EP | claimed |
| CN-104529781-A | A synthetic method of a chiral liquid crystal monomer, a cross-linking agent and an elastomer of the monomer | PRODUCT QUALITY SUPERVISING AND INSPECTING INST OF TAIZHOU CITY | 2015-04-22 | — | — | CN | claimed |
| US-20150080352-A1 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE | BAYER MATERIALSCIENCE LLC (US) | 2015-03-19 | — | — | US | claimed |
| EP-2822532-A2 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE | Bayer Intellectual Property GmbH (DE) | 2015-01-14 | — | — | EP | claimed |
| WO-2013131969-A2 | EFFECT OF THE POLYURETHANE FILM FORMER ON THE EFFICACY OF ACNE TREATMENT | BAYER MATERIALSCIENCE LLC (US) | 2013-09-12 | — | — | WO | claimed |
| US-8361492-B2 | Drug delivery system and methods of use | Ocugenics, LLC (US) | 2013-01-29 | — | — | US | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0792371-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0880509-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND PLANT-GROWTH REGULATORS | Hoechst Schering AgrEvo GmbH (DE) | 1998-12-02 | — | — | EP | claimed |
| WO-1998020864-A9 | USE OF SELECTED NON-STEROIDAL ANTIINFLAMMATORY COMPOUNDS FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES | — | 1998-08-27 | — | — | WO | claimed |
| WO-1998020864-A2 | USE OF SELECTED NON-STEROIDAL ANTIINFLAMMATORY COMPOUNDS FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES | UNIVERSITA' DEGLI STUDI DI BRESCIA - DIPARTIMENTO DI SCIENZE BIOMEDICHE (IT) | 1998-05-22 | — | — | WO | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997029095-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND PLANT-GROWTH REGULATORS | HOECHST SCHERING AGREVO GMBH (DE) | 1997-08-14 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0450097-B1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1996-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080352-A1 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE | UROD, CUTA, PUF60 | HSD17B10 22/4885KDM4E 4264/4885LMNA 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.